Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use Among Outpatients Diagnosed With COVID-19

Coronavirus disease 2019 (COVID-19) is a viral pandemic precipitated by the severe acute respiratory syndrome coronavirus 2. Since previous reports suggested that viral entry into cells may involve angiotensin converting enzyme 2, there has been growing concern that angiotensin converting enzyme inh...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of cardiology 2020-10, Vol.132, p.150-157
Hauptverfasser:	Bae, David J., Tehrani, David M., Rabadia, Soniya V., Frost, Marlene, Parikh, Rushi V., Calfon-Press, Marcella, Aksoy, Olcay, Umar, Soban, Ardehali, Reza, Rabbani, Amir, Bokhoor, Pooya, Nsair, Ali, Currier, Jesse, Tobis, Jonathan, Fonarow, Gregg C., Dave, Ravi, Rafique, Asim M.
Format:	Artikel
Sprache:	eng
Schlagworte:	ACE2 Adult Age Angiotensin II Angiotensin Receptor Antagonists - therapeutic use Angiotensin-converting enzyme 2 Angiotensin-converting enzyme inhibitors Angiotensin-Converting Enzyme Inhibitors - therapeutic use Betacoronavirus Coronavirus Infections - diagnosis Coronavirus Infections - drug therapy Coronavirus Infections - epidemiology Coronaviruses COVID-19 Emergency medical care Enzyme inhibitors Female Follow-Up Studies Humans Male Mechanical ventilation Medical records Middle Aged Mortality Outpatients Pandemics Peptidyl-dipeptidase A Pneumonia, Viral - diagnosis Pneumonia, Viral - drug therapy Pneumonia, Viral - epidemiology Receptors Regression analysis Respiratory diseases Retrospective Studies SARS-CoV-2 Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Treatment Outcome Ventilation Viral diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!